Lymphoma & Plasma Cell Disorders
Conference Coverage
Late-breaking abstracts highlight treatment advances in CLL, myeloma, and more
ASH President Kenneth C. Anderson, MD, and ASH Secretary Robert A. Brodsky, MD, gave a preview of four practice-changing studies.
News
Method identifies effective treatments for leukemias, lymphomas
An ex vivo drug screening method can reveal optimal therapies for patients with hematologic malignancies, according to research published in The...
News
PTSD can persist in cancer survivors
Cancer patients may experience lasting post-traumatic stress disorder (PTSD), according to a study published in the journal Cancer. Approximately...
Conference Coverage
CD22 CAR activity in B-ALL highlights promise of multispecific CARs
NATIONAL HARBOR, MD. – A new CD22-targeted CAR demonstrated clinical activity in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL)...
From the Journals
Cyclophosphamide after transplant reduced GVHD in myeloma patients
Anticancer agents may be more active after transplantation than before, researchers suggested.
News
FDA approves obinutuzumab for follicular lymphoma
Approval is based on a 28% lower risk of disease progression or death after 2 years for patients on the obinutuzumab-based regimen.
News
FDA expands approval of obinutuzumab
The US Food and Drug Administration (FDA) has expanded the approved use of obinutuzumab (Gazyva®). The drug is now approved for use in...
From the Journals
Rituximab key to survival after transplant for mantle cell lymphoma
The benefit of rituximab “stands out, and adds to the increasing body of evidence supporting this practice for all MCL patients after ASCT,...
Conference Coverage
Debate: Is MRD ready for prime time in multiple myeloma?
NEW YORK – Two leading multiple myeloma experts question whether it’s time to incorporate minimal residual disease measures into daily practice....
News
Parity laws don’t lower oral cancer drug costs for everyone
US state laws intended to ensure fair prices for oral cancer drugs have had a mixed impact on patients’ pocketbooks, according to a study...
News
CHMP wants to expand use of BV to include CTCL
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the approved indication for...